Welcome to the e-CCO Library!

P302: Precision medicine for a case with monogenic inflammatory bowel disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Schwärzler, J.P.(1)*;Zollner, A.(1);Dolejsi, T.(2);Enrich, B.(1);Mayr, L.(1);Sturm, W.(1);Tancevski, I.(3);Zschocke, J.(4);Adolph, T.E.(1);Tilg, H.(1);
Created: Friday, 14 July 2023, 11:05 AM
P302: Predictors of outcome in children with Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. T. Fioretti*1, C. Strisciuglio2, M. Martinelli1, P. Dolce3, G. Vallone4, A. Staiano1, E. Miele1

Created: Friday, 22 February 2019, 9:41 AM
P302: Pregnant women with ulcerative colitis are more likely than Crohn’s disease to exacerbate during pregnancy
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Bar-Gil Shitrit1*, A. Ben Yaacov2, D.M. Livovsky2, E. Goldin2, B. Koslowsky2

Created: Thursday, 21 February 2019, 9:14 AM
P302: Serum IL-6 is associated with treatment refractoriness in acute severe ulcerative colitis
Year: 2021
Source: ECCO'21 Virtual
Authors: Li Wai Suen, C.(1,2);Morris, R.(3);Choy, M.(1,2);Nigro, J.(3);Visvanathan, K.(3);De Cruz, P.(1,2);
Created: Wednesday, 2 June 2021, 4:12 PM
P303 Role of parietal healing by ultrasound in the evolution of patients with Crohn’s disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

P. Mayor Delgado, C.J. Suarez Ferrer, J. Poza Cordon, E. Martin Arranz, J.L. Rueda Garcia, M. Sanchez Azofra, M. Cuadros Martinez, M.A. Ruiz Ramirez, M.D. Martin Arranz

Created: Thursday, 30 January 2020, 10:12 AM
P303: Biologic Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease: Are we aiming high?
Year: 2022
Source: ECCO'22
Authors: Robertson, A.(1);Hawkins, I.(1);Wilkinson, S.(2);Patel, R.(3);
Created: Friday, 11 February 2022, 3:52 PM
P303: Factors associated with the development of extraintestinal manifestations in patients with ulcerative colitis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Yamamoto-Furusho*1, G. Sanchez-Morales2

Created: Friday, 22 February 2019, 9:49 AM
P303: Gastrointestinal infectious agents detected by Biofire FilmArray GI PCR panel stool testing in active inflammatory bowel disease are common and associated with a more benign course of IBD
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Limsrivilai J.1,2, Stidham R.W.3, Govani S.3, Waljee A.3, Gutermuth B.3, Brown A.3, Briggs E.3, Rao K.4, Higgins P.D.*5

Created: Wednesday, 20 February 2019, 10:36 AM
P303: Hyperbilirubinemia can be induced with azathioprin treatment in patients with inflammatory bowel disease: a hospital-based cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

W. Moon*1, K. I. Seo1, S. J. Park1, M. I. Park1, S. U. Lee1, B. C. Yun1, B. H. Han1, E. T. Park1, J. H. Kim1, S. E. Kim1, K. Jung1

Created: Friday, 22 February 2019, 9:41 AM
P303: Local Application of Autologous Platelet-rich Plasma leads to Sustained Healing of Crohn`s Perianal Fistulae – One Year follow-up Results from a Single Center Pilot Study.
Year: 2021
Source: ECCO'21 Virtual
Authors: Podmanicky, D.(1,2);Jezberova, M.(3);Lucenicova, J.(4);Bak, V.(1);Kadleckova, B.(5);Zelinkova, Z.(5);
Created: Wednesday, 2 June 2021, 4:12 PM
P303: Serological assessment of type XVI collagen reflects intestinal strictures in Crohn’s disease patients
Year: 2018
Source: ECCO '18 Vienna
Authors:

J.H. Mortensen1*, M.L. Olesen1,2, C. Jensen1, N. Willumsen1, P. Giuffrida3, M. Pinzani4, G. Mazza4, A. Di Sabatino3,4, M.A. Karsdal1, T. Manon-Jensen1

Created: Thursday, 21 February 2019, 9:14 AM
P303: Ultrasound is effective to identify mucosal healing in Crohn's disease patients : results of a cross-sectional study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yzet, C.(1);Brazier, F.(1);Hautefeuille, V.(1);Decrombecque, C.(1);Sarba, R.(1);aygalenq, P.(2);Venezia, F.(3);Buisson, A.(4);Pichois, R.(5);Michaud, A.(6);Fumery, M.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P304 Extranodal primary intestinal lymphoma in inflammatory bowel disease: An ECCO CONFER multi-centre case series
Year: 2020
Source:

ECCO'20 Vienna

Authors:

F. Phillips1, B. Verstockt2,3, D. Ribaldone4, I. Guerra5, N. Teich6, K. Katsanos7, R. Filip8, T. Molner9, K. Karmiris10, ECCO CONFER Investigators

Created: Thursday, 30 January 2020, 10:12 AM
P304: Faecal calprotectin as surrogate marker of transmural healing assessed using MRI in patients with Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Allimant1*, L. Messadeg2, R. Minet Quinard3, M. Goutte1,4, D. Bouvier3, F. Goutorbe1,5, B. Pereira6, G. Bommelaer1,4, C. Hordonneau2, A. Buisson1,4

Created: Thursday, 21 February 2019, 9:14 AM
P304: Intensified versus conventional infliximab induction in acute severe steroid-refractory Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Pedro, J.(1);Coelho Rodrigues, I.(1);Botto, I.(1);Fernandes, S.(1);Bernardo, S.(1);Gonçalves, A.R.(1);Moura Santos, P.(1);Valente, A.(1);Correia, L.(1);Tato Marinho, R.(1);
Created: Friday, 11 February 2022, 3:52 PM
P304: Leucine-rich alpha 2 glycoprotein reduces the necessity for endoscopic examination for activity evaluation
Year: 2023
Source: ECCO’23 Copenhagen
Authors: HayashiHayasix@0917, T.(1)*;Takatori, H.(1);Yamashita, T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P304: Patients with perianal Crohn’s disease have poor disease outcomes after primary bowel resection
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. M. Han*1, J. W. Kim2, J. H. Kim1, S.-J. Koh2, H. Yoon3, C. Lee4, J. P. Im1, J. S. Kim1

Created: Friday, 22 February 2019, 9:49 AM
P304: Predicting severity in Crohn's disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Gouveia*1, C. Gomes1, L. Glória1, J. Torres1, M. Cravo2

Created: Friday, 22 February 2019, 9:41 AM
P304: Rational infliximab induction dosing to achieve long-term deep remission in children with Inflammatory Bowel Diseases
Year: 2021
Source: ECCO'21 Virtual
Authors: Kantasiripitak, W.(1);van Hoeve, K.(2);Sabino, J.(3,4);Vermeire, S.(3,4);Hoffman, I.(2);Declerck, P.(1);Thomas, D.(1);Ferrante, M.(3,4);Dreesen, E.(1,5);
Created: Wednesday, 2 June 2021, 4:12 PM
P304: Zinc levels, interplay with ATG16L1 and disease outcome in Crohn's disease patients in the Swiss IBD cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Greuter T.*1, Franc Y.2, Kaelin M.3, Schoepfer A.4, Misselwitz B.1, Vavricka S.1,5, Rogler G.1, Biedermann L.1

Created: Wednesday, 20 February 2019, 10:36 AM